Organisation paid for research Program year 2024 Source: CMS Open Payments

Vantage Eyecare LLC

Neither a doctor nor a teaching hospital

Research payments

$334,441

51 payments

Through program year 2024, Vantage Eyecare LLC is reported as receiving $334,441 in research payments, across 51 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$24,192	4
2023	Research	$105,921	12
2022	Research	$73,552	11
2021	Research	$99,503	13
2020	Research	$22,122	8
2019	Research	$9,150	3

Breakdown

Who paid Research payments · program years 2019–2024

AbbVie, Inc. $175,022 23 payments
Allergan Inc. $148,209 23 payments
Kowa Research Institute, Inc. $11,210 5 payments

Studies the money was for Research payments · program years 2019–2024

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension $167,930 22 payments
A multicenter, open-label, single arm study in patients with open angle glaucoma or ocular hypertension who have not had previous laser trabeculoplasty treatment $115,145 14 payments
A multicenter, open-label, single arm study in patients with open angle glaucoma or ocular hypertension who have not had previous laser trabeculoplasty treatment $29,063 8 payments
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension $7,092 1 payment
K-321-201 $6,407 2 payments
K-321-201 $4,803 3 payments
Multicenter Double Masked Randomized Vehicle-Controlled Parallel-Group study of AGN-190584 for Participants with Presbyopia $4,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.